What's new
-
October 2, 2026
Safety
New
Revisions of PRECAUTIONS: Cladribine posted
-
October 2, 2026
Review
New
The new website “Overview of SAKIGAKE Designation“ launched.
-
October 2, 2026
Review
New
The English versions of GMPGCTP Annual Report FY 2025 have been published.
-
October 1, 2026
Int
New
PMDA-ATC Training Materials have been updated
-
September 30, 2026
Safety
New
MHLW Pharmaceuticals and Medical Devices Safety Information No.431 posted
-
September 30, 2026
Int
New
“For Industry - for development in Japan “ Updated.
-
September 30, 2026
Review
New
"Consultations" Updated
-
September 30, 2026
Events
New
Report of PMDA-ATC Generic Drugs Review Seminar 2026
-
September 30, 2026
Int
New
PMDA Updates (2026 No.3) posted
-
September 29, 2026
Safety
New
PMDA Risk Communications: Ibuprofen L-Lysine,etc. posted
-
September 29, 2026
Review
New
English Translation of Review Report: Jivi (Partial Change Approval)
-
September 28, 2026
RS
New
Regulatory Science Activity Report updated
-
October 2, 2026
New
The new website “Overview of SAKIGAKE Designation“ launched.
-
October 2, 2026
Quasi
Drug
New
The English versions of GMPGCTP Annual Report FY 2025 have been published.
-
September 30, 2026
All
New
“For Industry - for development in Japan “ Updated.
-
September 30, 2026
New
"Consultations" Updated
-
September 29, 2026
Drug
New
English Translation of Review Report: Jivi (Partial Change Approval)
Currently, there is no applicable information.
